Search details
1.
Therapy-related acute lymphoblastic leukaemia in women with antecedent breast cancer.
Br J Haematol
; 2024 Mar 31.
Article
in English
| MEDLINE | ID: mdl-38556836
2.
Trafficking between clonally related peripheral T-helper cells and tissue-resident T-helper cells in chronic GVHD.
Blood
; 140(25): 2740-2753, 2022 12 22.
Article
in English
| MEDLINE | ID: mdl-36084473
3.
Disruption of dNTP homeostasis by ribonucleotide reductase hyperactivation overcomes AML differentiation blockade.
Blood
; 139(26): 3752-3770, 2022 06 30.
Article
in English
| MEDLINE | ID: mdl-35439288
4.
Lack of RBC transfusion independence by Day 30 following allogeneic hematopoietic stem cell transplant strongly predicts inferior survival and high non-relapse mortality in acute myeloid leukemia patients.
Transfusion
; 64(2): 255-280, 2024 02.
Article
in English
| MEDLINE | ID: mdl-38225215
5.
Toxicities associated with tyrosine kinase inhibitor maintenance following allogeneic hematopoietic cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia.
Am J Hematol
; 2024 May 28.
Article
in English
| MEDLINE | ID: mdl-38804599
6.
Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar Study.
Blood
; 138(22): 2278-2289, 2021 12 02.
Article
in English
| MEDLINE | ID: mdl-34265047
7.
High response rates and transition to transplant after novel targeted and cellular therapies in adults with relapsed/refractory acute lymphoblastic leukemia with Philadelphia-like fusions.
Am J Hematol
; 98(6): 848-856, 2023 06.
Article
in English
| MEDLINE | ID: mdl-36880203
8.
Cladribine, Cytarabine, and Etoposide-Based Regimens Are Safe and Tolerable In Relapsed and Refractory Acute Myeloid Leukemia Patients.
Acta Haematol
; 146(6): 538-542, 2023.
Article
in English
| MEDLINE | ID: mdl-37708871
9.
Extramedullary disease relapse and progression after blinatumomab therapy for treatment of acute lymphoblastic leukemia.
Cancer
; 128(3): 529-535, 2022 Feb 01.
Article
in English
| MEDLINE | ID: mdl-34633671
10.
Acute Promyelocytic Leukemia: Update on Risk Stratification and Treatment Practices.
Cancer Treat Res
; 181: 45-55, 2021.
Article
in English
| MEDLINE | ID: mdl-34626354
11.
Outcome of Allogeneic Hematopoietic Cell Transplantation after Venetoclax and Hypomethylating Agent Therapy for Acute Myelogenous Leukemia.
Biol Blood Marrow Transplant
; 26(12): e322-e327, 2020 12.
Article
in English
| MEDLINE | ID: mdl-32866594
12.
Outcomes of Allogeneic Hematopoietic Cell Transplantation after Salvage Therapy with Blinatumomab in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia.
Biol Blood Marrow Transplant
; 26(6): 1084-1090, 2020 06.
Article
in English
| MEDLINE | ID: mdl-32035275
13.
Long-Term Outcomes of Allogeneic Hematopoietic Cell Transplant with Fludarabine and Melphalan Conditioning and Tacrolimus/Sirolimus as Graft-versus-Host Disease Prophylaxis in Patients with Acute Lymphoblastic Leukemia.
Biol Blood Marrow Transplant
; 26(8): 1425-1432, 2020 08.
Article
in English
| MEDLINE | ID: mdl-32416253
14.
Long-Term Outcomes of Patients with Acute Myelogenous Leukemia Treated with Myeloablative Fractionated Total Body Irradiation TBI-Based Conditioning with a Tacrolimus- and Sirolimus-Based Graft-versus-Host Disease Prophylaxis Regimen: 6-Year Follow-Up from a Single Center.
Biol Blood Marrow Transplant
; 26(2): 292-299, 2020 02.
Article
in English
| MEDLINE | ID: mdl-31536825
15.
Venetoclax and hypomethylating agents in FLT3-mutated acute myeloid leukemia.
Am J Hematol
; 95(10): 1193-1199, 2020 Oct.
Article
in English
| MEDLINE | ID: mdl-32628327
16.
Outcomes of Patients with Recurrent and Refractory Lymphoma Undergoing Allogeneic Hematopoietic Cell Transplantation with BEAM Conditioning and Sirolimus- and Tacrolimus-Based GVHD Prophylaxis.
Biol Blood Marrow Transplant
; 25(2): 287-292, 2019 02.
Article
in English
| MEDLINE | ID: mdl-30227232
17.
Ruxolitinib as Salvage Therapy for Chronic Graft-versus-Host Disease.
Biol Blood Marrow Transplant
; 25(2): 265-269, 2019 02.
Article
in English
| MEDLINE | ID: mdl-30201397
18.
A Phase 1 Trial of CNDO-109-Activated Natural Killer Cells in Patients with High-Risk Acute Myeloid Leukemia.
Biol Blood Marrow Transplant
; 24(8): 1581-1589, 2018 08.
Article
in English
| MEDLINE | ID: mdl-29597002
19.
Therapy-related acute lymphoblastic leukemia has distinct clinical and cytogenetic features compared to de novo acute lymphoblastic leukemia, but outcomes are comparable in transplanted patients.
Haematologica
; 103(10): 1662-1668, 2018 10.
Article
in English
| MEDLINE | ID: mdl-29903756
20.
Erythroblast macrophage protein (Emp): Past, present, and future.
Eur J Haematol
; 100(1): 3-9, 2018 Jan.
Article
in English
| MEDLINE | ID: mdl-29032607